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The human body hosts complex communities of microbes that differ at each body site.  These 
microbes can impact human physiology and health through production of metabolites that directly 
affect human cells or microbial community composition. The human vagina hosts a limited number of 
Lactobacillus species, but in the dysbiotic condition bacterial vaginosis (BV), the bacterial community 
shifts to complex communities of diverse anaerobes. 
BV is a highly prevalent condition in the United States, where it affects up to 29% of women and has 
been associated with numerous adverse outcomes including preterm birth, pelvic inflammatory 
disease, and elevated risks for sexually transmitted infections including HIV. It is unclear how BV-
associated bacteria mediate these increased health risks, and there have been few studies linking 
vaginal bacterial communities to detailed metabolite profiles. 
Identification of the metabolites present in the vagina of women affected by this condition may 
elucidate how different bacterial populations thrive, and this knowledge could be used for disrupting 
metabolic pathways present in deleterious bacteria. Dr. Srinivasan and coworkers from Dr. David 
Fredriks’ Laboratory (Vaccine and Infectious Disease Division) at Fred Hutch pursued a 
metabolomics-based approach wherein gas or liquid chromatography was coupled with mass 
spectrometry to measure hundreds of low molecular weight metabolites in vaginal fluid and to link 
these metabolites to particular bacteria detected by PCR. 
"The novelty of our study," explained Dr. Srinivasan, "is the breadth and depth of the approach, and 
the linking of important metabolites with concentrations of bacteria and clinical findings in women. 
BV is associated with strong metabolic signatures affecting multiple pathways including amino acid, 
carbohydrate and lipid metabolism, with significant differences in concentrations of 62% of 
metabolites detected in women with BV." The study indeed demonstrated a different pattern of 
metabolites in women with BV. Such metabolites correlated with the presence of BV-associated 
bacteria and were associated with characteristics distinctive of BV, such as an elevated pH, amine 
odor, vaginal discharge and presence of clue cells, which are vaginal epithelial cells covered by 
bacteria. Furthermore, antibiotic treatment resulted in the increase of metabolites prevalent in 
women not diagnosed with BV. 
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Women with BV have metabolic profiles marked by much lower concentrations of amino acids and 
dipeptides, concomitant with higher levels of amino acid catabolites and polyamines, suggesting that 
BV-associated bacteria may use amino acids as carbon sources. In contrast, lactobacilli are known 
to metabolize sugars such as glycogen derived from the host and do not appear to rely on amino 
acids as their primary carbon source which are more elevated in women not diagnosed with BV. 
"This study has advanced our understanding of the functional status of bacterial communities in BV. 
Insights from this work may provide opportunities for developing novel approaches for treatment or 
prevention of BV," commented Dr. Srinivasan. Given the absence of a vaccine and a durable 
therapy for BV, these results give hope that the solution to this condition is getting closer. 
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Bacteria, metabolites and their associations in the human vagina. 
Bacteria in vaginal fluid from a woman with bacterial vaginosis (BV) 
are detected by fluorescence in situ hybridization in the top panel. A 
selection of metabolites in vaginal fluid (left) and a heat map of 
associations between metabolites and vaginal bacteria (right) are 
presented in the lower panels. 
 
